Levothyroxine sodium
NDC 87063-091, Levothyroxine Sodium, tablet, from ASCLEMED USA INC..
- Product NDC
- 87063-091
- Status
- Listed
- Labeler
- ASCLEMED USA INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212399
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87063-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM150 ug/1
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87063-091-00 | 87063009100 | 1000 TABLET in 1 BOTTLE (87063-091-00) |
| 87063-091-30 | 87063009130 | 30 TABLET in 1 BOTTLE (87063-091-30) |
| 87063-091-60 | 87063009160 | 60 TABLET in 1 BOTTLE (87063-091-60) |
| 87063-091-90 | 87063009190 | 90 TABLET in 1 BOTTLE (87063-091-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/42a26f8a-dc67-42e4-abb0-d2602afb1b7d
Use it
Look up 87063-091 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87063-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87063-091. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.